Core Insights - Microsoft is experiencing significant long-term warning signals as a result of a sharp selloff, pushing the stock into a critical technical zone [1] - The stock has fallen to $397.29, down 7.67% in the latest monthly candle, breaking below the $410 level and testing a key long-term support zone [2] Technical Analysis - The focus is on the 50-month moving average (MA), which has served as Microsoft's primary structural support since December 2011, previously leading to bullish reversals [3] - A confirmed monthly close below the 50-month MA would indicate a major technical breakdown, with the next key support at the 100-month moving average near $300, aligning with significant Fibonacci retracement levels [4] - The monthly Relative Strength Index (RSI) is testing the crucial 44 support level, with a potential break below opening the path toward the oversold threshold of 30, which could coincide with a price decline toward the 100-month moving average [5] Financial Performance - Following the fiscal Q2 earnings report in late January, Microsoft reported a 17% revenue growth to $81.3 billion, exceeding estimates, but concerns arose from a $37.5 billion capital expenditure primarily for AI data centers and GPUs [6] - Despite robust demand for AI and cloud services, heavy spending has led to skepticism among investors, with some major funds trimming positions due to fears of delayed returns and potential margin pressure [7]

Core Insights - MRNA has experienced a pullback to a low of $36.66, indicating a potential successful test of support near the rising 10-week moving average at $37.74, suggesting readiness for a bullish trend continuation [1] - The key resistance level is identified at $55.20, where multiple indicators converge, and breaking this level could lead to accelerated bullish momentum [2] - Long-term upside targets for MRNA include the 200-week moving average at $92.99, with an initial target potentially being the 38.2% Fibonacci retracement at $76.72 [3] Group 1 - MRNA fell to a low of $36.66 this week, indicating a successful test of support near the 10-week moving average at $37.74 [1] - The area around $55.20 is identified as a key resistance level, with several technical indicators reinforcing this [2] - The 200-week moving average at $92.99 is highlighted as a long-term upside target, with the potential for MRNA to reach the top side of the falling channel [3] Group 2 - The bullish reaction following the low suggests that the pullback may complete the first phase after a long-term breakout [1] - The confluence of indicators at $55.20 suggests that breaking this level could confirm a continuation breakout [2] - The analysis indicates that the 38.2% Fibonacci retracement at $76.72 may be reached before the 200-week moving average [3]

Group 1: Delta Airlines - Delta Airlines is experiencing a slight decline of about 2% year-to-date, but remains stable overall [3][4] - The company has a strong reputation for reliability in consumer travel, particularly in corporate travel with premium services [4][5] - Delta's business model includes domestic, international, and cargo operations, with cargo accounting for approximately 9% of its revenue [5][6] - The stock is approaching the 50-day moving average, which historically has provided a bounce point for the stock [7][14] - Current technical analysis indicates potential support levels around 68 and 64-65, with a bearish short-term outlook but bullish medium to long-term sentiment [8][10][14] Group 2: General Motors - General Motors (GM) has had a mostly flat performance this year, but has recently increased its dividend by about 20% [17][18] - GM is focusing on internal combustion engines (ICE) while managing costs effectively, avoiding overcommitment to electric vehicles (EVs) [18][19] - The company reported a slight revenue miss but beat on earnings, indicating a strong financial position [20][29] - Technical analysis shows a potential bounce at the 50-day moving average, with a bullish long-term outlook if this level holds [21][31] - Current trading strategies suggest a long-term bullish position with options expiring in January 2027, with a break-even point around 88 [31][32] Group 3: Uber - Uber has faced challenges due to increased competition in both ride-hailing and delivery services, leading to concerns about its growth potential [34][35] - The stock is expected to decline further, with a potential support level around 60, indicating a bearish outlook [36][37] - Technical indicators suggest a strengthening downward trend, with moving averages diverging and RSI indicating oversold conditions [39][40] - Trading strategies for Uber suggest a bearish position with options expiring in June 2026, targeting a break-even point at 69.50 [42][43]

Historically, buying at the 200-week moving average has been very good. I trust math, but be prepared for more pain. Don't nibble if you can't handle a potential 30% drop. Long term is key. #Math #LongTerm https://t.co/bL6NnaLpop ...

Core Viewpoint - Shopify Inc (NASDAQ:SHOP) stock experienced a pullback in January, reaching a nearly six-month low, but has recently shown signs of a potential short-term rebound with shares up 1.8% to $133.59 [1] Group 1: Stock Performance and Indicators - The stock is currently within 0.75 of its 260-day moving average, with shares remaining above this level 80% of the time over the past two weeks and 80% of the last 42 trading sessions [2] - Historical data indicates that similar conditions have led to a 100% success rate of the stock being higher one month later, with an average gain of 12.1%, suggesting a potential target price of $149.75 [2] - The 14-day relative strength index (RSI) for Shopify is at 16.4, indicating it is in "oversold" territory, which often precedes a short-term bounce [4]

Bitcoin closed January at $78,635 (-38% from ath)200 Week Moving Average $58kRealized Price $55k, decreasingRSI dropped below 50, blue: official bear territoryHistorically BTC could drop to 200WMA/RP levelsHowever bull has been weak (no red) so bear might be shallow https://t.co/Mxps9J5wLB ...

Market Performance - The S&P 500 reached a new record high this week, momentarily surpassing 7,000 for the first time, but concluded the week with a modest gain of 0.3%, now 0.56% off its all-time high from January 12, 2026 [1] - The S&P 500 is currently up 1.37% year to date, while the S&P Equal Weight Index is up 3.28% year to date, indicating a stronger performance for the equal-weighted index [5] Historical Context - The S&P 500 reached an all-time high of 1565.15 on October 9, 2007, before experiencing a significant drop of approximately 57% during the Global Financial Crisis, closing at 676.53 on March 9, 2009 [2] - It took over 5 years for the index to reach a new all-time high on March 28, 2013, closing at 1569.19 [2] Volatility Insights - The index experienced its largest intraday price volatility of 10.77% on April 9, 2023, the highest since December 24, 2018, which had a volatility of 19.10% [4] - The average percent change from the intraday low to the intraday high over the past 20 days is 0.78% [4] Moving Averages - The S&P 500 has been above the 50-day moving average since January 20 and above the 200-day moving average since May 12, with the 50-day moving average above the 200-day moving average since July 1 [3]

#BITCOIN HAS BROKEN BELOW THE 100 WEEK MOVING AVERAGE.DYOR. https://t.co/VBVnWqLMe9 ...

BTC just lost the 2-year moving average for the first time since 2022.We've also lost the November 2025 lows, and are 7% away from losing the 2025 yearly low. https://t.co/TWXGBMJhSu ...

Core Insights - Elevance Health Inc (NYSE:ELV) experienced its largest single-day percentage gain since May 2024, reporting profits of $547 million, although this was not sufficient to recover from its worst day since March 2020 due to proposed Medicare Advantage payment rate increases of only 0.09% for 2027 [1] - The stock is currently near a trendline with historically bullish implications, which may assist in reducing its 14.2% year-over-year deficit [1] Technical Analysis - According to Schaeffer's Senior Quantitative Analyst, ELV is within 0.75 of its 100-day moving average's 20-day average true range (ATR), having remained above this level 80% of the time over the last two weeks and 80% of the past 42 trading sessions. This pattern has historically led to an average gain of 5.7% one month later [3] - A similar upward movement from the current position could push ELV back above $363 [3] Market Sentiment - The health insurance stock's 50-day put/call volume ratio at major exchanges is higher than 99% of annual readings, indicating that an unwinding of pessimism could provide positive momentum for the shares [4] - Options for ELV are currently affordably priced, with a Schaeffer's Volatility Index (SVI) of 33% ranking in the 27th percentile of annual readings, suggesting that the stock has exceeded option traders' volatility expectations over the past year [5]